Related Experiment Videos
[Analgesia-sedation during extracorporeal lithotripsy (ESWL)]
S Pascale1, A Maione, G Ferrante
1Casa di Cura Malzoni-Villa dei Platani, USL n. 4-Avellino.
Minerva Anestesiologica
|March 1, 1992
Summary
Premedication with benzodiazepines effectively reduces anxiety and opioid use during extracorporeal shock wave lithotripsy (ESWL). This approach improves patient comfort, even when stronger sedatives are needed, thanks to specific antagonists.
Area of Science:
- Anesthesiology
- Urology
Context:
- Extracorporeal shock wave lithotripsy (ESWL) is a common procedure for kidney stones.
- Analgesia and sedation are crucial for patient comfort during ESWL.
- Anxiety management is a key component of effective ESWL sedation.
Purpose:
- To evaluate the effectiveness of benzodiazepine premedication in managing patient anxiety and pain during ESWL.
- To assess the impact of benzodiazepines on opioid consumption and overall patient experience.
- To explore strategies for managing deeper sedation when necessary during ESWL.
Summary:
- Benzodiazepine premedication significantly reduces patient anxiety before ESWL.
- This premedication lowers the requirement for opioid analgesics, leading to a less unpleasant pain experience.
- For patients requiring deeper sedation, benzodiazepines with a stronger hypnotic effect can be used, with their effects reversible by specific antagonists.
- This allows for the safe use of these agents in day-hospital ESWL settings.
Impact:
- Improved patient comfort and satisfaction during ESWL procedures.
- Reduced reliance on opioid medications, potentially minimizing side effects and risks.
- Enhanced feasibility of day-hospital ESWL by enabling effective and reversible sedation management.